Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy
NCT06846086 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2025-03-26
Summary
The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.
Conditions
- Cardiomyopathies
Interventions
- DRUG
-
Melatonin 10 MG
Melatonin
- DRUG
-
placebo
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-20
- Primary Completion
- 2026-01-01
- Completion
- 2026-02-01
Countries
- Egypt
More Related Trials
-
Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
NCT03037047 ·Status: UNKNOWN ·Phase: PHASE4
-
Desflurane-induced Myocardial Protection
NCT02019797 ·Status: UNKNOWN ·Phase: PHASE4
-
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
NCT05838846 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
NCT05117346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
NCT04666454 ·Status: RECRUITING ·Phase: PHASE4
-
IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion
NCT06466278 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
NCT07103655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
NCT03855826 ·Status: UNKNOWN ·Phase: PHASE4
-
Cell Therapy In Dilated Cardiomyopathy
NCT00333827 ·Status: COMPLETED ·Phase: PHASE3
-
Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy
NCT01115504 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of COR-1 in Heart Failure
NCT01391507 ·Status: COMPLETED ·Phase: PHASE2
-
Pericardial Resection to Treat Heart Failure
NCT03073668 ·Status: COMPLETED ·Phase: NA
-
PHOspholamban RElated CArdiomyopathy STudy - Intervention
NCT01857856 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
NCT04667598 ·Status: UNKNOWN ·Phase: PHASE2
-
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
NCT04128878 ·Status: COMPLETED
-
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
NCT07241104 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
NCT05582395 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction
NCT06964607 ·Status: COMPLETED
-
Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
NCT01235156 ·Status: UNKNOWN
-
Acute Cardiovascular Events Triggered by COVID-19-Related Stress
NCT04368637 ·Status: UNKNOWN
-
Effect of Empagliflozin on Ventricular Repolarization.
NCT04117763 ·Status: COMPLETED ·Phase: PHASE4
-
Myocarditis Treatment Trial
NCT00000524 ·Status: COMPLETED ·Phase: PHASE2
-
Colchicine Versus Placebo in Acute Myocarditis Patients
NCT05855746 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Nesiritide in Diastolic Heart Failure.
NCT00309868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723 ·Status: RECRUITING ·Phase: PHASE2/PHASE3